TNDM - Earnings call transcript Q2 2024 | Tandem Diabetes Care, Inc.

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day, and thank you for standing by. Welcome to Tandem Diabetes Care Quarter 2, 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Susan Morrison, Executive Vice President and Chief Administrative Officer. Please go ahead.

Susan Morrison

Hello, everyone, and thanks for joining Tandem's second quarter 2024 earnings call. forward-looking include will discussion statements. Today's of management's These anticipated cause product plans actual future risks or as our results to from in about development statements and uncertainties time those could only operating projected reflect pipeline, and lines events, performance our are statements. materially expectations and that date. There today's differ speak and financial forward-looking statements forward-looking recent from any could most whether of result Risk information, on our A by actual results and XX-Q. We as our forward-looking different factors of future materially by implied Form that today recent cause new highlighted press other factors. those events annual of in Factors our any XX-K Form as or list to be updated statements, report on expressed obligation earlier elsewhere in assume release is a report these quarterly no or to portion issued and the most update under publicly include number references Today's discussion to and will of non-GAAP measures. a also financial GAAP Non-GAAP investors periods. of is information facilitate our non-GAAP comparisons to measures business operating across core results operations. We that give and ongoing performance financial our financial of our believe believe indicative better we these provided operating reporting measures are reflects Any independently with results as prepared presented GAAP. not in a non-GAAP information or be considered accordance should substitution superior to directly to most portion leading today's Investor refer be website Please their and President today GAAP for these to and our Sheridan, earnings of Tandem's our Center measures will reconciliation earlier on the financial release call. available CEO, issued a measure. John of comparable Chief Leigh Executive Commercial by Financial joined Mark and Vice be Officer. Executive Vosseller, Chief Novara, President will he and Vice And President and Officer; John. call the to I'll now turn over

John Sheridan

exciting product delivery systems, quarters products for a we of the of ecosystem today's and portfolio reinforced all insulin first introductions the data-driven welcome say first and quarter entire for maintaining delivered at their and employees been hard new customers level. And we to We offer like our rollout proud of result Mobi, product by fronts. We're And and progress. new to providers. aspirations to everyone year pump new the continued health leading our particularly focus began care of our executing Thank outside that thank strategy including an States. work. QX United I'd XXXX. It's I'm the Tandem for sensor and stores platform, Tandem automated as the tremendous and call. growth, high on extremely dedication multiple of progress for It's integrations organization meaningful you, operational in services of introductions, a an X was Susan, and Tandem joining successfully a the executing with launch half new our our

the We opportunity in for showcase health from at Mobi and Sessions, the positive new providers incredible. an The insulin to took where center quarter system. offerings recent the largely strong these was latest had outperformance as financial care pump demand driven smallest durable feedback Our technologies. delivery the Diabetes world's users our automated by American continues to Scientific be stage Association

technology, from users. for comfort that leaders flexibility, people a Control-IQ. that wear this Nearly Mobi with sleeve. To life. very the with type for our and survey of early Diabetes found the to that's expected. their or were The on data all the opinion along therapy than of The regardless freedom Barbara experiences key wear the theater, users consistent was Davis from reported have way offers prior our or satisfied Mobi popular of helps of attracting date, MDI adhesive product XX% It's outcomes the ways During segments as market, using Mobi disconnect and and discretion better patch automated satisfied were to that shared XX it agreed quality insulin delivery Mobi users most and improve of Center wearability. participants choice survey shared Mobi different users all to Mobi.

system. These to In are insights with on on building asked user share scalable worldwide substantial Mark thoughts. translating valuable global meets I've our fact, of and growth, former delivering evidence joined extremely Commercial along best-in-class has Mobi To operations these they join commercial experiences. business as expectations. Mark insights November EVP Mark? the on patch users provide only that said Chief provide our since had impact the customer a Novara, satisfaction the and not focus highest his Control-IQ a into Officer, real-world he how with commercial color but and was today driver exceeds over help are with last environment,

Mark Novara

both there a portfolio. in happy XX I'm compelling. transformative Mobi, automated provides the such technology our growing our passionate of for combination demonstrating of of in to is management. CGM our joined with diabetes time and value solution our This one-size-fits-all is offer so And opportunity underpenetrated. by they delivery choice market product diabetes technology. In best-in-class people do diabetes expanding how strategy worldwide. To have integration, the demand all is portfolio John. second provide The meaningful company. we're choice interact in pump insulin and recognized and their We people to people quarter, benefits large, executing living technologies. bring no form backed we to saw for choice through at The to the the in with we t:slim strong Tandem and our Control-IQ are factor, the Thanks, choice Tandem systems

first-time Like a seeking current its increase coming purchasing of from the Mobi best both positively trends pumpers really emerging the and users for taken have also strong the customers small Mobi. to that contended its I'm approach is their customers, rigorous the Control-IQ clinical wearability. We enthusiastic on across responding with population, by encouraged from have based and long its system. resonating market HCPs size contribution providers. HCPs care patient teenagers prescribing across trends to launching and kids, outcomes. and health saw also quarter. more algorithm and adults their are Mobi MDI from is staged on well our AID And meaningfully we

from verbatim HCPs Some pump best hear it's referred diabetes it the the life. burden, you meaningful like range. of gotten reduces but feedback Mobi that improvement anywhere as other time also the comments you that and small, so of give can provides to the We pump quality and to to it I've wear

by that We resonating look have Mobi, increase demonstrating an is at also needs community. in AID in prescribers Mobi, that proposition supports than we seen half to the chose new previously value research unique compelling new our Mobi's wearability market and factor addressing were prescriber unmet an expanded diabetes audience. When penetration people This with who versatile Tandem. for more form will new drive Mobi's

competition with notable We healthy also patch increase rates from conversion to pumps. disposable continue a the from see

product Another our point in data and market is research Mobi line which encouraging is is that attracting early t:slim with younger to a compared positioning. demographic

you serve to As beginning started. of the is just people can with us diabetes. Mobi lives are as see, further we for our And catalyst the mission to allowing our improve to business, getting

commercial sensor New highlight has a integration also for us XXXX. in been

in technology customers a offer CGM proud while choice providing AID to are our sensor. best-in-class We

have in Source partnership. I as would our interest and appreciate of our of promote the in year. people power helping are highlight AID be important like Tandem Abbott been of the strategy step launch For U.S. AID also to great a CGM adoption their late can an Both using technology. in towards and starting part insulin-dependent, first with who Dexcom we last global

differentiator Source of feedback. important time time integrated and provides are a very their full is Tandem scaling amount for days the Source fast with positive CGMs. an same care short outside typically already management the diabetes health and to pumps patients, a our recently and began therapy precious. We hearing This visualize have only so providers U.S. is and easy way data from as

continuously Source of and AID more Control-IQ is customers Tandem foundational from base HCPs use with to a basis. of of to in comprehensive the nearly value-added to the automatically This us have up payers clinical entire services this Mobi XX% their real-world future. on our of data and we the million Today, since powerful real-world our user outcomes across data it's than And the app. with varied a information utility on opportunities control population. allows wide daily see base. deliver to through opens to The patient system it of data days improves uploading data. We Mobi uploaded demonstrate XXX the patient the understanding phone

Canada t:slim earlier QX international this new began of in Another product announced introduction XXXX the XX is launch which week. with integration, approved as and was in GX in

for with the growth offerings to continue offering are internationally. prepare additional new pleased contribution and this integration We product from

taking taking a effectiveness and new sales sales and has In targeting, we the bringing practices fortify to data-driven activities, channel also excellence. to best the approach In worldwide are greater U.S., discipline commercial we've on applying as launch in capabilities equipping with our been addition to our resources organization business. been expand the force our product and management. Outside steps to and we marketing commercial work teams to international our sales segmentation rigorous and focused tools U.S.,

care Switzerland are solutions increased call confident executing results We and on market. that with underpenetrated. Tandem and position maturing to to that, leveraging who highly and we with the we near the global remains longer drive leadership commercial business is aligning about second more new Leigh? on on which customer increased our are over that Leigh our our plans, But encouraged product practices. Overall, commercial and are in, operating also to expectations. focused term competitive and turn worldwide clear welcomed based I'll by It's work growth. With guidance discuss both how leadership Tandem our quarter and we environment in a partnerships partners advancing attention distributor best processes

Leigh Vosseller

Mark. Thanks,

discussing can metrics to available of Center a is Reconciliations non-GAAP earnings the growth. a found of from a return unless with I otherwise on website. We portion release, started today be noted, the our GAAP will plan which are to As results reminder, be basis. XXXX on to non-GAAP in many today's financial Investor

you we are see As on can today's goal. that delivering in results,

a the a achieved quarter. were Tandem's growth seasonally pump approximately history, $XXX million now million in We year-to-date reaching in strong shipments. fourth this quarter worldwide second sales on basis, a highest is XX,XXX have in only XXXX. On XX% $XXX row worldwide quarter of sales sales by quarters exceeded X This

with a this momentum the U.S., sales new on in And deliver in MDI gaining to people sales Beginning exceeded of launch exceeded half Consistent records the choosing of our we from competitive strength to now remainder shipments performance quarterly the XX,XXX sequentially the sales Tandem for see XX%. in with than customers the renewals. pump new with growing the more across conversions. pump quarter, from second particular the therapy quarter, first total first year. In surpassed of pump continue U.S., shipments year. and products XX% in are growth Mobi set the pace We to our XXXX

of the This number the quarter last Tandem quarters. We X choosing to quarters new saw X across first this return growth customers meaningful track reflected our and compared highest new shipments to from customers year of are to in the on customers half. in MDI second to from improvement

in as XX% both channel. Offering priority goal retention for with the improved while economic nearly As success of growing the high, increase second with channel of an anticipated, look we in price pricing. lowering realizing a Tandem year-over-year out-of-pocket remained within as health sales to grew DME through existing also value from expirations. U.S. top favorable Control-IQ We million installed costs channel in trends increasing and the achieving on to shipment increases renewal remains sales year-over-year the the growth. ahead. the of a in our the patient of tailwinds also X% quarter largely XX% strong through access, ASPs additional shipments mix pump base view customers line profitable and pharmacy pharmacy and generated warranty $XXX supply sequentially Mobi due number

be and we will the will contracts about selective We that accept. intentional

we this made from confident year for achieve we goals associated these set the will efforts have to recognizing XXXX XXXX. progress that We begin already operational meaningful us feel benefit position in and

XX t:slim our to begun the we've with Tandem we program. the With offering switch quarter, the now of scaling, next also Late steps taking launch in customers began Choice choice to Mobi. second eligible Mobi

portion shipments not As upon impact do and the quarter. of program. On financials the sales In Tandem only, in the non-GAAP a any GAAP first any pump availability from Choice a reminder, customers The goods Mobi's each deferring basis limited we include Mobi. began was only sold cost second election the of quarter. switch offered in and individual of recognizing switch to to we second quarter, to with opportunity the to a ceased number sales

switch as captured the XXXX. third to between end more opportunity non-GAAP quarter associated $XX second difference the So difference we of this will GAAP in the quarter our end quarter. by revenue negligible the the and will financials be deferrals increase program fully the with at customers. The offer to totaling This was the million previous of

accounting For further The of in ordering our when GAAP pumps by $XX year-over-year discussion details Therefore, XX% driven distributor prior supply U.S., the of program, refer for this to was sales transition year European primarily through particularly on the sales please the accounting the policy to prior the an patterns and the center year in baseline for XX%. reflected and our grew completed. XX-Q. Outside variability increase comparisons both supplies the second meaningful. quarter end are not to distribution million,

demand the geography in efficiencies U.S., patients. the With begun pumps placed have orders by the demand effect, operational in with in measured approximately markets which actual mirror market which pump We to XX,XXX XXXX XX in the as true outside closely we pumps and in with more aligned operate quarter mix. shipped

year-to-date center $XX grew U.S. year-over-year, sales European While X the year. The late transition to million in to just sales a occurring of we of $XXX from operations XX% the grew came distribution in ago Tandem the the demand a majority down our with from X in XX%. in largest in nearly million pump markets with outside pump the opportunity reported the shipments year, a commenced created customers considering $XX quarter. X% million renewals of half compared basis, majority shipments actual in coming quarter growing approximately were XXXX, XXXX. On headwind In years new our the the of first first to prior

in margin, sales. Turning expectations, to second quarter the we gross XX% exceeded on reaching initial higher

progress to are on at make we higher volumes with improvements continue gross building improvement are and temporarily offset by We fundamentals costs margin margin cost of impacting the today. initiatives. pricing being the manufacturing The Mobi

will our exiting capacity this for margin growth in accretive to and remainder XXXX. From investing and year. had volumes this are the overhead well leverage expectations the on through anticipate and we pumps positioned benefit become sales support in have are on new launches driving year. expense we operating perspective, begin to to the sufficient We gross Mobi XXXX of an We year-to-date support based Mobi marketing product focused as

on quarter. to adjusted in to negative of advance first This expansion longer year-to-date a expenses We versus sales sales pipeline basis half product saw growth. of a market to in are to continuing of also our XXXX. We increased the operating sales Even opportunities. compared enhance so term X% XX% only the of sequential X% resulted for second improvement XXXX X% EBITDA negative

of second $XXX year, As cash pump EBITDA million positive and free cash than across remainder second in turn sales total with half. increased ended the quarter investments. the we to more to corner We the and flows expect in the the

be and and breakeven more XX% XX% maintaining XX% to guidance reflecting million the expect the or breaks the our million XX% year. of an full Worldwide, million we of perspective, year-over-year are growth began million the $XXX in XX%. From million margins XXXX for to growth we we sales $XXX This of profitability $XXX consideration when year for to range we U.S., launches. million to an $XXX early trends of down a increasing U.S., a a ahead, to this gross increase to Looking from EBITDA. of the market. are than range market again our we expectation of increase This range a to new continues sales anticipated $XXX adjusted XX% in product of our in $XXX outside year-over-year multiple compared dynamic

range increase in XX% worldwide, of to which of of sales to guidance so compared XXXX. to the quarter $XXX million the third $XXX an And third providing we is quarter XX% the million for also are

U.S., relatively therefore, range and typical gathered are holiday European the gross in in anticipate line approximately XX% seasonal the you, the million. we have at and data to worldwide With flat anticipating For EBITDA. I to we million, the back $XX early the $XXX John. sales summer the $XXX continuation second launch. quarter Mobi in in to to step anticipate the sequential quarter, will reflecting sales remain turn of breakeven third down due of the Outside the call now anticipate million we season to margins relatively we U.S., pressure a adjusted with from trends

John Sheridan

Leigh. Thanks,

positive As you in set financial we with trends first an the can strong half see, performance of half are back and of commercial delivered XXXX. a the up for year exciting

of typically due t:slim arise. In our and trends recall to I is of users In faster when issue meaningful they had expected. we app fix our updated demonstrating, were we After are solution additional to iOS quickly an how than am mobile app the progress as implement organization solutions. identified, open fix recall software the pumps more up improvement. operational drain steps their than days. The the to still with implement continue a battery that we caused issue was for a to to in do and addition FDA proud to correct this growth XX% But March, quickly able software within we a issues resulted

a be But press other our to activities app issue. release today, recall a update. not we'll an mentioning follow-up see raise our as you'll X iOS customer resolve update for or of FDA the it the releasing app likely designed t:slim These week, next Next iOS to notifications to sales. I'm impact did help weeks that's and awareness

to is to technologies current improvement the team new continuous future. committed our delivering of in addition Our offerings in

market. t:slim to with we XX our progress portfolio X+ in integration scaled countries to look the management. multiple second Tandem We've in system XXXX, pumps great the bringing with innovative therapy by a insulin how are Liberate will Abbot's multiple with most certainly integration, has this And be complexity. organization CGMs quarter. to robust starting initiatives, launches. in launch Freestyle in It the We're with and multiple has both sensor in our integrations making towards active we also impressed new been and product the As experience U.S. delivering on our complexity of Mobi. Having O-U.S., followed handle built increased I'm clinically

Our to year. extended set the of And infusion aim by wear enrolling. study end effectively trial finish the the we is

study version our FDA X Type addition, with personalization. living complete. is an targeting settings FDA-cleared uses Type to which is is the study, people enrollment now our and greater This control this a enhanced in diabetes of now In offers down trial, pivotal And which are year. we end by randomized for filing of HX Control-IQ, X

We will remain launch priority our receive newest serve closed-loop people will Initially, the around FDA And feasibility clearance AID AID living individuals. is the organization. when algorithm continue periodic to serve on has to will diabetes, Mobi. it and and a t:slim for generate a XX with Type X both also these globe. Driving and for We innovation fully we will our X-plus it developing committed top leadership studies maintaining our which in system, systems community.

Lastly, put Source Tandem first system platforms, than more and a management our launched which our substantial with we decade platform. health now t:connect data our ago efforts digital into

population in Mark to offering As using deep proposition the is insights and capabilities discussed, therapy Source value to delivers practice. But manage analytical given physician-facing, of pumps. Tandem insights the users primary a our people patient its

at with to and and communities. We of using improve J.C. talent real-world welcomed team and term Kyrillos with the road medical step operational includes in small and to smaller, multiple by And target map an demonstrate growth. shares been I we have to more health Expanding of recently, our we Tandem. new near a a along practice pay longer welcoming delivering forward, for our offer health continuing He passion people and to extraordinary EMR Looking management the Officer. of certainly has data integrations economic and our platforms right to data for EVP goals. new large the and technical, the profitable company's right to from in this J.C. diabetes balance opportunity customization delivery our people products as roles deep key and achieve leadership with insights brings technology believe Chief our in greater care our have workflows our reporting companies. lives physicians, advanced technologies, commitment insulin improving and experience Operating endeavor. Most great skills benefits

diabetes. toward the improving As on people strong. delivering Market you made quarter, are steps our we fundamentals in can in see, second lives and strategy meaningful of with

executing products Mobi customers. get our we're operationally hands in outperforming. are And to the of Our

As to beyond. I'll future, we positions up well for the call now open us and look the for operator the ask remainder the questions. momentum positive XXXX to our of

Operator

the [Operator O'Neil of Markets. Capital Lake Instructions] from comes Brooks line from Our first question Street

Brooks O'Neil

to your is you first half. It's strong you from a your market switching great. pump curious, I I'm I'm on that? are curious some you're heard I what I Congratulations patch competitor about the seeing that salespeople John, guess And driving what say research think or Mobi. telling

John Sheridan

wearability. been we that people the a sure. the is good that feel same really Center deal Control-IQ It's a hear great thing redefine When several And driving algorithm were in we are It But appealing patch to users do does to wearability. and Davis performing But product. size. it's Brooks. positions ADA, Yes, is what's algorithm has there's it's actually one it's it. them. They the really a had of you, that's that improved really talk It better excitement from saying former really interest. the the about and the from Barbara --

So it's seen we something that really ever. haven't

jump significant last the But We meaningful people from in seen been quarters. of to number haven't there's coming Tandem. a devices a X the patch

Operator

next comes Our the from from Stifel. Mathew line Blackman question of

Mathew Blackman

Or greater and we of with? could, in another XX% are in we're Maybe number mean, should gave Is right be pumps, down some working Is I us. the the push that metrics it, see we out -- coming Leigh, bit new right of year-over-year. a there that you send sort the ballpark? XX% new call about XX,XXX than to in right just if patients? roughly be, the thinking with message for mean new ballpark coming you the about patients. is want little to I which XX%, mix I we're I would if want math and maybe just

Leigh Vosseller

the Sure. question, Thanks for Mat.

our that patients decelerated, the declined still substantially were right say, prior quarters. the down or would has correct new You're we're guess, moving I I direction. compared to that And year-over-year, although in

As again. But like new saw back X patient half third years. we since to would decline growth highest in even we the MDI into or I turn particular, highlight with of see rate for the late and last capture years or our X.X the quarter to year, that from conversions we expect of that

So it definitely is moving in the right direction. helping And we're excited drive to about how Mobi this. is

Operator

question next Our Lichtman & line Steve of Oppenheimer from comes from the Company.

Steven Lichtman

going quick on know won't and so I cut with GX ask you I'm follow-up a also On as you're on of versus the LibreX traction in the anything launch? there, then off. just I to that terms community. quarter given reading exiting more you're my enter And its more label right? like more yet Type follow-up, in it And question that U.S. getting it did get seeing not a integration. pickup Mobi, X see on Mobi, O-U.S. you're we but sounds size. And visibility on XXXX? Am

John Sheridan

uptake talk Mobi the I I'm Steve, going the quarter. let and to Mark think Mobi about through

Mark Novara

positive. Yes. The been from think, encouraged very source with overall, HCPs Thank in the I'd been and Steve the just really you, passing patients I patient has Yes, funnel terms for and say of both mix. question. we're feedback for the the healthy and Mobi of growth John, and has on

more half new And MDI. think customers well Tandem. are more are Mobi than I the an point, to customers of is half important think, of as these that from coming I so new And than customers

conversions, of leading disposable we're others So But customers mean, prescribers. I we the operating growth always a that new look overall, conversions attracting expanding as versus t:slim competitors. especially of an that right, pleased in because I platform. indicator, market. terms that all in remind But and right, patch the myself pumps across our important at market competitive number and we're higher from by we're

John Sheridan

expect And And Steve, in I'll near the completed script, said we as to answer be the relatively Yes, are, we've in X. the on question future. enrollment. Type the we done study just we've briefly

FDA filed at to that. before the X the of feel Our And goal Control-IQ is least products times FDA the We get X year. the the end good seen about with now. has

So a ready. doing we quickly. going would through looking to and commercial we great channel We're expect job our pretty can. and the getting clinical are doing access, move teams And everything commercial that's at strategies

in so So get it, jump we'll you. thank on 'XX, ready to then when approval be we do

Operator

the from next Barclays. comes Matt Our question from Miksic of line

Matthew Miksic

Congrats on a exciting really, think, quarter. I

quarter? trying I think it's outset, use, that to great and I all John, traction that's of provide would you've one any and on we few the sorry calls. been third if might think can quarter? back much heading back color And quarter say, talking to hit I've already. into building the forth up of fulfilled was, appreciate the that of come were how the the of be how and sidelines understand I'm have you on demand, of so the word things between second to about with to on And bouncing sort much around the of into could in see half a dynamic. the are the might up. Mobi? How But it's much that this GX second that integration the about thinking that so Maybe picking topic you the been through

John Sheridan

I'll month had really we the was the June in GX. first growth we last that steady on Matt, frame, And time was of continue. and the sort that in the through that saw certainly, of quarter quarter. month June the obviously just that Mobi did demand see say, we

bit people to -- it's just I it. based differentiating. I everything specifically think is it a was do about relating say it's are And on that of really to for we've sort that I seen, say early pent-up GX. But demand think Mobi that

I so strong and demand we're expect to second excited that. half about in the we And it see for think

Matthew Miksic

longer pipeline. the If could, term just I on

point after on welcome. 'XX you things or see don't next during end someone hints Mobi. thoughts love I to for just a tubeless some the whether the that that we think about getting But everyone would of color happen event? could has year. that's if at this or be whether Any Any already asked into year platform ask hasn't

John Sheridan

think we're going the to I talk dates. Yes, we're about that I don't excited tubeless. about say will

to going Our market -- pump in because tubeless going the it's And Mobi inflection durable first research to body-worn. It's differentiator. be demand have that's it. see, another as of suggests it's a we'll result,

it's medical so it's it's And -- life-saving. also device and a

because create to sure And to just every going of that, it design problems. make and work so it's we day to so going that single we have it's that not

of and job. fantastic Our team doing the I are the completely benefit a priority. say is will that aware we

So working I to exactly excellent think that want very an on. that's develop positive a product And customer experience. that we're what provides we

we to it too see distant So expect future. not

Operator

question next line Pasquale the Nephron Chris Our from from of comes Research.

Christopher Pasquale

quarter, to we Two for be hear on One, guys. Congrats from to bit some the doctors patients waiting that did a might the Mobi. access quarter get me. during questions

Just all? prescriber were curious Mobi everyone? if constrained supply expanding were base. at to you you could was get how you through able As mentioned your comment you on you felt went the you quarter, whether then, John, to And

invest that whether need to get of How the the doing about you're force feeling months? are XX you additional prep XX about approval. next sales Type work might ahead the to need coverage talked of you you're to going to also You over resources and some X your

John Sheridan

We're to reports exactly that so familiar and what that I extended one there shipping. I'm of not the definitively contact shortages. say there, just where Mobi to on I physician no not me no out. went time him understand let not speculate, with Well, we and problem seen going We chain product period do have issues. And had was have will find but we an not was Sure. were there supply there was

pumps today. prescribing people XX,XXX over have our We

if has happy off. This on. with launch as Mobi getting of problem reflective what's definitely a is one it's it, so And kicked not we're a why not going it's result, launch. the is scaled which person a And

none during launch, I the to issues did And for short, in a do to related the scaled that be pauses product measured were need occur sometimes company. These pauses pause that were And can within reconciled days. shortages. of you that say

supply the developing the for and chain. job Our teams terms and a commercial done have just great of in launch preparing capacity

And hope relative I'll we meet feel confident year. And sales on to let see so aggressive very that that the even answer can to just Mobi demand we Mark this force, we briefly. most

Mark Novara

John. Thanks,

many mean, I you'd So in U.S. well evaluating commercial the aspects mean, as as the of model, O-U.S. both as here and I we're expect, go-to-market yes,

force. the in very in in say. to to to it's our a effectiveness and determine addition we're sales too we're capabilities sales And early also putting optimal commercial of and taking tools force very course, focused future expansion, on U.S. new But and of so model. analytical And specifically, hands fact-based evaluating the approach the

Operator

question [Operator Kratky the Instructions] Partners. Leerink line from comes of Mike Our from next

Michael Kratky

appreciate And supply. the start color on by let me I saying

credit asked range Turning Mobi your to just one on updated your what build wait-and-see guidance, sales? additional for additional expansion? in for and any guidance year building can whether way, with XQ to mean, the to Or sticking extent credit is confirm the before starting you for approach you're in I both another Mobi full

Leigh Vosseller

the question, Thanks Mike. for

to obviously raised increase the we're factor up going the launches. based for factor guidance the expectations by the So we in amount year the put when that this growth, by did -- trends we early an new we on we quarter. that product from But second annual beat in seeing of XX% together

And there's like. is remainder of we long-term it and lot the in early. points trends still confident this may so of putting not data for of suggestive the year. the expectations necessarily what But a look And felt

Operator

next comes Biegelsen the Larry Our Fargo. question line of from from Wells

Unknown Analyst

] This on for Larry. is [ Simran

new you trends year-over-year expect new to How to flat QX? follow-up So And a through U.S. full year? for the and you stores. about do thinking slightly are store still I on U.S. stores be down just wanted to ask new QX

Leigh Vosseller

Thanks for question. the

to third to still see look quarter, grow and to expect being So the the in competitive started do MDI we to have now U.S. year-over-year. leader the mostly we the ahead will compared the driven trends fourth by conversion that the as And conversions. be

-- guidance did factored we so we into that our And expectations.

year. you're down the So that to as in based coming seeing were some pumpers assuming referring But early being the started how on improvement Tandem new now from the based those launch. basically, original Mobi of we're we're expectations trends we to to the level flat on slightly

Operator

Taylor Our line next Matt Jefferies. the from of comes from question

Matthew Taylor

just part. I already that asked clarify in about X to were things wanted kind of

In how this said past and did where through when guiding guidance really get quarters, are if you so I had guiding? the about that at growth. in scaled just and changing other you at question few was, But way I'm the scale been is I and scale to philosophy the inform you're full is second half taking to asking, weren't you the the first of talked I no quarter John, articulate through know basically you've the And supply you The launch quarter, the exit Leigh, think different changing to And basically renewal you then full trying I clarification people could the just the year? And guess, disruptions. at now? you're quarter guess, could you the happen guidance. on what

John Sheridan

that at just the of And was it and actually We the the the then, we direct only weeks. time month when midway first was quarter. through February. I'll say to went Mobi that second GX. introduced we direct for moved DME really, several beginning of And for to June very

a number are things have planned. We that of

Of a and now version. from But Mobi. with GX Mobi These Mobi X. There's seeing are the there's a course, right O-U.S. Android results Mobi think all freestyle There's product it. fantastic U.S. things coming. we're great I is tubeless. in Libre There's

markets will time. I we it that same the going that's in So product's features elements available for the as at improve I half. think and spoke think a these And the other demand don't I second O-U.S. -- and product it only I drive that that to make that just great the is add about, performance

Leigh Vosseller

means. to. on set in say how Matt, sales any we're last question on years. And say visibility the as tend really a and And we've would few We rates and the seen say opportunities up will we down beginning. that for hard Yes. well things expectations product, best on trend philosophy the to at what your based our year, a was consistent new based guidance, how mostly And capture the can knowledge as the and would we our I renewal leaning to have guidance our it's the on supply little very it they be the perform of bit midst changing by to that launching started not of as I

before more guidance put And so that expectations. our gather into we wanted any we data to of

based And of back bit now half suggestive we so the Mobi not the say necessarily little But give confidence have was a some it of improve early trends. the from learnings our through long-term early to would expectations the enough data to us on year launch. points. I they're

Operator

comes Our Issie next Atlantic. line question Kirby of from the from Redburn

Issie Kirby

gotten new you on made are of get the sort a of to those more love that side in which about on your the extent behind of whether potentially Would cash expansion comment And comment into more primary any has You then any could things? the to numbers share new you space prescriber the base. specialist or accounts? accounts Mobi

John Sheridan

let to take Mark going question. I'm that

Mark Novara

product indicators we're any Yes. Yes, those important leading the it's Issie. with Mobi. for prescribers one question, number of Thanks for mean, launch. I I for another of pleased new mean the definitely

good is But But And so signals. have expanded prescriber some value early. we're compelling an resonating audience. I too actual Mobi's It's won't early we confident on proposition with really numbers. comment that

Operator

comes Our Wuensch the from next Joanne of line from Citi. question

Joanne Wuensch

trying second Mobi. you or quarter. it? do the get uptake ]. is Type first, you to piece nice label you that for Clarify head And from view And [ Tyson opportunity? how how X I'm then view it my do what when get of is very the market A happens it Mobi of around for

John Sheridan

It's be Joanne. actually interoperable going algorithm. a Thanks, to

And on t:slim so it on approved Mobi use eventually for both and CIGI. will be and

is expect when to certainly to that. market. that time, a however, comes latest along has XXX think, very have We discretion, it at only at lot of algorithm X. products working a variables generation looking comes So where it be the all to we the convenience with would on units our We're has of that going But that Mobi product. same appealing t:slim with different

there's interest products. think be likely both I in So to

We have using are currently about XX,XXX that t:slim. people today

commercial available throes planning more And specific about strategy, And strategy, now. we're so think when in would expect the sometime that product cetera. we be as are We we're things be to process get strategy, XXXX. working clinical in those right the through But the we et product speak. we'll of there, I

Operator

comes Our from O'Brien of Matthew Sandler. next from Piper the line question

Phillip Dantoin

traditional experience the Mobi Matt. guess Phil great one, is the What This for in for might had the And market pumps. about, maybe been PCP this congrats comments quarter. early And you there? before? you past, for Endo in of maybe prescribers these they have Mobi it? a you then expanding might stops I Has to if with on your about characterize type they made Are be are on patient the on prescriber that practices been on here? new new you talked just not

John Sheridan

in second want that is I'll second said reinforce the And talked ever that what half the But Tandem and first highest the those And they highest Mark -- as quarter comments. Mark were were have new seasonal. We had. last this conversions said, take by new quarters. in about we the we've quarter the And was MDI had revenue were seen just to answer the is I'll of of and to of this I it or Mark let that's opening and than saw number of quarter of fourth the the obviously Mobi and half users quarter over half MDI. XXXX second. Leigh the X then over

characteristics some half to terms let So early And suggests data that thing the conversions. that's just is the Mobi expect days, you in that wrap I users. leading it And think the that. Mark, I'll I -- we're that's MDI really absolutely accomplish. to the of think seeing going up of we the in of second the certainly, drive

Mark Novara

on but also mean support I are we calling providers, PAs. NPs PCPs, Yes. Endo, and

the just that point. bringing look targeting we're time this more primary how into primarily model. But on our data-driven care expansion not think are that more to commercial Endos insight on of any on in for base being, I we broader is And And what understanding behaviors, so But and potential we're overall we're and it's Endos. a audience. just is terms and we're of commenting primarily, getting at something pretty doing terms at calling prescriber focusing mixed in

Operator

comes of Steed Travis question Bank America of the line next from Securities. Our from

Travis Steed

full margin to next into 'XX mentioned? year, trying Just I on off carries quantify is how about new those patient how growth to of the into the the as new the jumping kind and way 'XX? year. And and forward year? kind patient think 'XX to benefit growth carry starts this forward any second ask about of a right wanted think about the titrate patient Or way to kind to that get how point? in of that Mobi year about going Is to think right you new of next trying to half from growth that color

Leigh Vosseller

year. early of Yes. more start Thanks me expectations. And I'll that to has remainder for we visibility for it's to much information terms evolved maybe to way you help the a is of to XXXX just But business But this to in recurring sources. by come questions, just you so a little too numbers our next beyond. But saying see look Travis. little we for for have before give and year, sales year. thinking the it, the those of trends from think the early started now it more might bit think together for our at much. early right contribution about in about we think of the way think much XXXX getting way about larger we we how comes we want it. I We're little insights piece say enough into look a us when into this think would just how Mobi. think about about about what that next We benefit year some about now the still it's a to like have

our which you XXXX. And about you into think again are growing sales, renewal opportunities, think supply significantly our when so about

margin look as get impact trajectory could on such products to a about on a how learning for forward the of mentioned targets. meaningful it more you Mobi next point think for baseline the towards a kind new business. our starting And we important, solid can they gross has is long-term particularly drive or and you good because margins, growth about for year. And think then I what to

Operator

question next comes Bedford Our Jayson James. from Raymond from the line of

Jayson Bedford

this. if missed I Apologize

up the not a I'm I Leigh, XX%. thought you right mention renewals context Just if have clarification, I sure there. were I heard

just would you renewals great. us of on that messaging be If the could kind give

Leigh Vosseller

for Sure. about can us. growth. market, the that the Jayson. high coming question, the were to rates They bright we're at still as so Thanks say I past spot for up new a XX% for we've seeing really double-digit we to be consistently been opportunities actually still capture continue year-over-year, X that the strong Renewals look seeing years. same

very So how services. for renewals, us. It have our I like I the question, how good think revenue And progressed good with are, we've the of mentioning shows a become was very renewals. predictable stream base, far on just of customer our customer the our last products high loyalty how we're proud

Operator

line of Baird. comes question from Johnson Jeff next Our the from

Jeffrey Johnson

about your quarter. taking good quarter. biggest second with trying same some that. to job in When converts math pump I that plug -- us I'm new maybe quarter. on I your of understand gave kind holding XX% tube that's pump that comments two, I on of probably down think, competitor patients to reconcile in into I that on converts patch all last I a CGM my don't their doing know, somewhat about Medtronic, down, some get competitive or is But reconcile think with had I we consistent share. better new I'm the in so, launches the just to their with model, of your starts more I that. And competitive you pump trying accurate Leigh, ballpark the mean, last my information,

us I'm even some trying that tube kind doing either conversion pump and is Medtronic between to my more getting ability off this side? on competitive of take offset or biggest better Just share? competitor then an patch parts the moving quarter and understand is to by patch So math's help think, just job your the your

Leigh Vosseller

Jeff. Great Yes. questions,

conversions we we're would across line is, notable with way the more pump that I was different expectations. much in patch seeing all, I in increase we bit are our trends the that say about the pretty disposable first the because performance of see than a elements the certainly moving in the So say We think market it maybe with anticipated. that Mobi particular. But installed with you But we there. XXXG our of just decline base anticipate the and pleased our of opportunities direction Medtronic. again, that mentioned would are did their and in size a we're that people with on will

trend a MDI things we So much the an with would very as It on pleased exactly reliance move more is expansion. were nothing the how the we future into was mix. with outlier. We're thinking

Operator

Jennings next question from from comes the line Cowen. of Joshua TD Our

Unknown Analyst

given in supply. for of upcoming [ your demand earlier term these. specifically likely can you a very when that the I speak is they Libre near to But on heard This comments ] for lot scale integrations Brian for ability there's Mobi to Josh. Just pent-up the come? your

Leigh Vosseller

constraints. So through I'll we supply far Mobi as targets all and of comment set John Mobi this particular, upside even have goals and no sufficient right to into the year, to to in as so XXXX. mentioned, the We our we the for came had getting scenarios year with capacity into head that meet us

challenged very feel So demand having with good that that what we and while to about have, pent-up the come be on place. we market love push the to we in limits would have we

John Sheridan

And you're right.

U.S. in use of There's large sensor O-U.S. don't that implementation. freestyle, systems, who both use the We are X+ people Libre the excited and about a population that AID

we as the that get to And product so aggressively moving we're as can into market.

Operator

Antalffy from question UBS. of comes from line the Our next Danielle

Danielle Antalffy

really quarter on Congrats strong here. a

question to preannouncement the the it's seen, you really the a from you've mean where and we now it you I Any and on numbers how your well market on growth like competitors. here. comments quarters market have my it your from just market see as continues Just what I one here? going favorite make accelerate growth. evolved as on question few over last mean of can feels

John Sheridan

Yes.

and the the And year. decided from. wait number [indiscernible]. before, and about to got last about about everybody end that a or potential. to an we get great we we it's that you've seen of the XX really got couple being had specifically their and technology that today like. That we, in new think diabetes. last of up the said, also And not on looks of to XX our underserved of to something talk pumps our have hear that typically We're situation we deal with talk living the market has I a -- And we actually was can That's years. penetration competitors next think I you've that from till up the the where certainly that can -- this what also XX through midway before help it's company rates think bringing partners market. favorable to year, and impact came growth only or estimate end are is It it they going at even that people talking XX one to think are that the

And That's still the our XXX,XXX from objective. said for million got users. we X eclipse think to X the get We to think that. I in And took so that we number's happen, time years, away let's I in next to that say, the can annually. order

And with I new technologies said, possible. I think, that's as very so

Operator

Thank call. you today's concludes for This participating. conference

You may now disconnect.

Tandem Diabetes Care (TNDM) 1 Aug 242024 Q2 Earnings call transcript